Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Multi-timescale conformational dynamics of the SH3 domain of CD2-associated protein using NMR spectroscopy and accelerated molecular dynamics.

Salmon L, Pierce L, Grimm A, Ortega Roldan JL, Mollica L, Jensen MR, van Nuland N, Markwick PR, McCammon JA, Blackledge M.

Angew Chem Int Ed Engl. 2012 Jun 18;51(25):6103-6. doi: 10.1002/anie.201202026. Epub 2012 May 8. No abstract available.

2.

Solution structure, dynamics and thermodynamics of the three SH3 domains of CD2AP.

Roldan JL, Blackledge M, van Nuland NA, Azuaga AI.

J Biomol NMR. 2011 Jun;50(2):103-17. doi: 10.1007/s10858-011-9505-5. Epub 2011 Apr 26.

PMID:
21519904
3.

The high resolution NMR structure of the third SH3 domain of CD2AP.

Ortega Roldan JL, Romero Romero ML, Ora A, Ab E, Lopez Mayorga O, Azuaga AI, van Nuland NA.

J Biomol NMR. 2007 Dec;39(4):331-6. Epub 2007 Oct 9.

PMID:
17922258
4.

Atypical polyproline recognition by the CMS N-terminal Src homology 3 domain.

Moncalián G, Cárdenes N, Deribe YL, Spínola-Amilibia M, Dikic I, Bravo J.

J Biol Chem. 2006 Dec 15;281(50):38845-53. Epub 2006 Oct 3.

5.

Hepatitis C virus NS5A is able to competitively displace c-Myc from the Bin1 SH3 domain in vitro.

Aladag A, Hoffmann S, Stoldt M, Bösing C, Willbold D, Schwarten M.

J Pept Sci. 2014 May;20(5):334-40. doi: 10.1002/psc.2618. Epub 2014 Feb 24.

PMID:
24616074
6.

Accurate characterization of weak macromolecular interactions by titration of NMR residual dipolar couplings: application to the CD2AP SH3-C:ubiquitin complex.

Ortega-Roldan JL, Jensen MR, Brutscher B, Azuaga AI, Blackledge M, van Nuland NA.

Nucleic Acids Res. 2009 May;37(9):e70. doi: 10.1093/nar/gkp211. Epub 2009 Apr 9.

7.

General order parameter based correlation analysis of protein backbone motions between experimental NMR relaxation measurements and molecular dynamics simulations.

Liu Q, Shi C, Yu L, Zhang L, Xiong Y, Tian C.

Biochem Biophys Res Commun. 2015 Feb 13;457(3):467-72. doi: 10.1016/j.bbrc.2015.01.018. Epub 2015 Jan 17.

PMID:
25600810
8.

Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.

Wybenga-Groot LE, McGlade CJ.

Cell Signal. 2013 Dec;25(12):2702-8. doi: 10.1016/j.cellsig.2013.08.040. Epub 2013 Sep 7.

PMID:
24018043
9.

The SH3 domain of Eps8 exists as a novel intertwined dimer.

Kishan KV, Scita G, Wong WT, Di Fiore PP, Newcomer ME.

Nat Struct Biol. 1997 Sep;4(9):739-43.

PMID:
9303002
10.

Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.

Kim J, Lee CD, Rath A, Davidson AR.

J Mol Biol. 2008 Mar 28;377(3):889-901. doi: 10.1016/j.jmb.2008.01.063. Epub 2008 Jan 31.

PMID:
18280496
11.

Redox-regulated conformational changes in an SH3 domain.

Zimmermann J, Kühne R, Sylvester M, Freund C.

Biochemistry. 2007 Jun 12;46(23):6971-7. Epub 2007 May 19.

PMID:
17511475
12.

Solution structure of the first SH3 domain of human vinexin and its interaction with vinculin peptides.

Zhang J, Li X, Yao B, Shen W, Sun H, Xu C, Wu J, Shi Y.

Biochem Biophys Res Commun. 2007 Jun 15;357(4):931-7. Epub 2007 Apr 17.

PMID:
17467669
13.

Identification of a link between the SAMP repeats of adenomatous polyposis coli tumor suppressor and the Src homology 3 domain of DDEF.

Matsui C, Kaieda S, Ikegami T, Mimori-Kiyosue Y.

J Biol Chem. 2008 Nov 21;283(47):33006-20. doi: 10.1074/jbc.M800420200. Epub 2008 Sep 11.

14.

Promiscuous binding nature of SH3 domains to their target proteins.

Agrawal V, Kishan KV.

Protein Pept Lett. 2002 Jun;9(3):185-93. Review.

PMID:
12144515
15.

Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.

Vidal M, Goudreau N, Cornille F, Cussac D, Gincel E, Garbay C.

J Mol Biol. 1999 Jul 16;290(3):717-30.

PMID:
10395825
17.

The redundancy of NMR restraints can be used to accelerate the unfolding behavior of an SH3 domain during molecular dynamics simulations.

Duclert-Savatier N, Martínez L, Nilges M, Malliavin TE.

BMC Struct Biol. 2011 Nov 24;11:46. doi: 10.1186/1472-6807-11-46.

18.

UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.

Oneyama C, Nakano H, Sharma SV.

Oncogene. 2002 Mar 27;21(13):2037-50.

19.

The LIM and SH3 domain protein family: structural proteins or signal transducers or both?

Grunewald TG, Butt E.

Mol Cancer. 2008 Apr 17;7:31. doi: 10.1186/1476-4598-7-31.

20.

Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands.

Feng S, Kasahara C, Rickles RJ, Schreiber SL.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12408-15.

Supplemental Content

Support Center